iDexis
  • About
  • Services
  • Orders
  • Product Range
  • Blog
  • Clients
  • Contact us
Understanding Allergies: Types, Triggers, and Treatment Options
Featured
Pippa Spies (Pharmacist) Uncategorised 29 July 2026 0 minutes read

Understanding Allergies: Types, Triggers, and Treatment Options

Allergies are a common immune condition in which the body's defence system mistakenly identifies a harmless substance, such as a food protein, pollen grain, or insect venom, as a threat. This immune response produces the itching, swelling, and inflammation typical of an allergic reaction. In more severe cases, it can spread systemically and become life-threatening, a condition known as anaphylaxis.

Notably, this immune response does not occur on first contact with a substance. Allergies typically develop in two stages. The first is sensitisation, which occurs on initial exposure to an allergen: the immune system encounters the substance, wrongly flags it as dangerous, and begins producing specific IgE antibodies against it. This stage usually causes no visible symptoms, so a person can become sensitised without ever knowing it.

It's only on subsequent exposure to the same substance that these IgE antibodies, now primed and waiting, trigger immune cells to release histamine and other chemical mediators, producing the classic allergic reaction. This two-step process explains why someone can eat a food or use a product for years without issue, then suddenly react to it.

Understanding the main types of allergies and the broad treatment approaches used to manage them can help patients recognise symptoms earlier and engage more confidently with their own care.

Types of Allergies

Allergic rhinitis, commonly known as hay fever, occurs when the lining of the nose becomes inflamed in response to airborne allergens such as pollen, dust mites, mould spores, or pet dander. It typically presents with a runny or blocked nose, sneezing, and itchy or watery eyes. It may be seasonal (tied to specific pollen seasons) or perennial (with symptoms persisting year-round due to ongoing exposure to indoor allergens).

Food allergies develop when the immune system reacts to specific proteins found in foods such as peanuts, tree nuts, shellfish, eggs, milk, or wheat. Reactions vary widely, from mild itching or hives to anaphylaxis, involving throat swelling and a dangerous drop in blood pressure.

Skin allergies can appear as hives (urticaria), eczema (atopic dermatitis), or contact dermatitis. These may result from direct skin contact with a trigger, such as certain metals or fragrances, or occur as part of a wider allergic response to something eaten or inhaled.

Insect sting allergies, most often linked to bee or wasp stings, cause localised swelling and discomfort in most people, but in sensitised individuals can trigger a rapid, whole-body allergic reaction. Because these reactions can escalate quickly, this category is considered one of the higher-risk forms of allergy.

Drug allergies occur when a person's immune system reacts to a specific medication, with symptoms ranging from a mild skin rash to a severe systemic reaction. Because the consequences can be serious, keeping an accurate and up-to-date record of known drug allergies is an essential part of safe healthcare and pharmacy practice.

Prevention: The First Line of Defence

Before considering treatment, it's worth stressing that avoiding a known trigger is, in most cases, the single most effective way to manage an allergy. Medication can control symptoms once a reaction has started, but prevention reduces how often that reaction happens and lowers the risk of it becoming severe.

Practical prevention varies by allergy type: avoiding a specific food and checking ingredient labels carefully, using allergen-proof covers on bedding and reducing humidity to limit dust mite exposure, monitoring pollen counts and keeping windows closed during high-pollen periods, being cautious around known insect habitats if venom-sensitive, and ensuring drug allergies are clearly recorded on medical files to prevent accidental re-exposure.

Working with a healthcare provider to properly identify specific triggers, through allergy testing where appropriate, is what makes meaningful prevention possible.

Treatment Options

Treatment decisions should always be made with a healthcare provider, but management of allergies generally falls into a few broad categories.

Antihistamines act by blocking the action of histamine, the chemical mediator largely responsible for the itching, swelling, and rhinorrhoea characteristic of an allergic reaction. They are generally used as first-line treatment for mild to moderate symptoms such as allergic rhinitis and hives.

Corticosteroids exert a broader anti-inflammatory effect and are administered in various forms depending on the site of involvement, including intranasal preparations for allergic rhinitis and topical formulations for skin allergies and eczema. In more severe or acute reactions, a short course of oral or injectable corticosteroids may be administered under medical supervision to achieve rapid control of inflammation.

Emergency treatment is critical for anyone at risk of anaphylaxis. This usually means having a fast-acting, self-administered treatment on hand at all times, along with a clear emergency action plan worked out in advance with a healthcare provider.

Conclusion

Allergies range in severity from the localised discomfort of allergic rhinitis to the systemic threat of anaphylaxis, but each presentation stems from the same underlying process: an immune system sensitised during an earlier, often unnoticed, exposure, then primed to react on subsequent contact with the same allergen. Antihistamines, corticosteroids, and related treatments remain effective for controlling symptoms once a reaction has begun, but prevention, through accurate identification of triggers and consistent avoidance, remains the most reliable means of reducing both the frequency and severity of allergic reactions. Anyone experiencing recurrent or worsening symptoms, particularly respiratory difficulty, facial or throat swelling, or involvement of multiple body systems, should seek prompt medical attention. Taken together, accurate allergy testing, informed prevention, and an individualised treatment plan offer the most effective path to long-term symptom control and improved quality of life.

iDexis Responds to Recent Reports and Confirms Legal Appeal
Featured
Pippa Spies (Pharmacist) Uncategorised 14 July 2026 0 minutes read

iDexis Responds to Recent Reports and Confirms Legal Appeal

iDexis, a fully licensed compounding pharmacy, is aware of recent media reports concerning the alleged seizure and recall of products compounded by the company, as well as related public health concerns.

A number of these reports are inaccurate and require clarification.

These publications have appeared more than a month after the matter was argued before the Gauteng High Court and following the granting of an interim interdict against iDexis.

The company has instructed its legal representatives to apply for leave to appeal the judgment. iDexis has been advised that several of the findings have final effect and are therefore appealable. An application for leave to appeal has accordingly been lodged.

Products Handed to Inspectors

During an inspection conducted at iDexis's fully licensed Pretoria premises on 11 May 2026, a number of compounded products were voluntarily handed to inspectors representing the South African Health Products Regulatory Authority (SAHPRA) and/or the South African Pharmacy Council (SAPC) following requests that the products be made available for inspection.

To the company's knowledge, neither SAHPRA nor the SAPC has, to date, conducted or disclosed the results of any testing performed on those products.

By contrast, independent testing commissioned by iDexis found no evidence of any breach of sterility. The company therefore maintains that the products were safe for use and that appropriate compounding procedures were followed. This position is supported by an independent expert report that has already been provided to both SAHPRA and the SAPC.

Regulatory History

iDexis is concerned by what appears to be a developing public narrative suggesting that SAHPRA and the SAPC only recently became aware that the company was compounding the GLP-1 and GIP products that later became the subject of litigation involving Novo Nordisk.

That narrative is inconsistent with the regulatory history.

The company's legal representatives informed SAHPRA of iDexis's specific compounding activities several years ago. Thereafter, both SAHPRA and the SAPC conducted inspections at the company's premises.

Those inspections resulted in favourable grading by the SAPC, and neither regulator raised material objections regarding the company's compounding activities prior to the inspections conducted in May 2026.

The compounding of GLP-1 and GIP products was taking place at the premises during those earlier inspections and was capable of being observed by inspectors. Accordingly, any suggestion that these activities were concealed from, or only recently discovered by, the regulatory authorities is rejected.

As previously indicated, we respect the court and we have ceased compounding GLP-1 and GIP products after the judgment was handed down. We remain committed to conducting our business lawfully and with due regard for public health and safety.

Ongoing Legal Processes

Appeals have also been lodged against the relevant findings and decisions of SAHPRA and the SAPC. 

iDexis remains committed to exhausting the internal remedies prescribed by law. Should those processes fail to resolve the disputes fairly and lawfully, the company intends to pursue the appropriate relief before courts of competent jurisdiction.

The company remains of the view that certain public statements and publications attributed tovSAHPRA and the SAPC are inaccurate, materially prejudicial, and have caused significant harm to its business and reputation.

Concerns Regarding Regulatory Consistency

iDexis is also concerned that it appears to have been singled out, notwithstanding that a number of compounding pharmacies throughout South Africa are understood to be compounding similar products.

The company is further aware of information suggesting that one such pharmacy may be associated with an individual who performs inspection functions for SAHPRA. This raises legitimate concerns regarding consistency, transparency and potential conflicts of interest. iDexis reserves all of its rights in this regard.

Commitment to Patients and Healthcare Professionals

iDexis does not intend to litigate these matters through the media. However, continued media enquiries and the repetition of inaccurate allegations have made it necessary to place the company's position on record.

No further statements will be made at this stage.

iDexis remains committed to the quality and safety of its compounded medicines and to serving the interests of patients, healthcare practitioners and retail pharmacies.

The company will continue to apply the highest appropriate quality standards, pursue available legal remedies through the prescribed processes, and take all necessary steps to vindicate its position and restore its reputation within the South African compounding pharmacy sector.

Kind regards,

Ruaan Louw (Managing Director - iDexis)

Chronic Stress and the Immune System: Inflammation, Infection Risk, and Immune Balance
Featured
Pippa Spies (Pharmacist) Uncategorised 11 June 2026 0 minutes read

Chronic Stress and the Immune System: Inflammation, Infection Risk, and Immune Balance

Introduction

Most people think of stress as a mental experience - something to push through, manage, or simply endure. Biologically, it is something more consequential: a coordinated response involving the nervous, endocrine, and immune systems. When a stressor is detected, two major response systems activate. The sympathetic nervous system triggers the immediate fight-or-flight response, releasing adrenaline and noradrenaline. The hypothalamic-pituitary-adrenal (HPA) axis follows, signalling the adrenal cortex to release cortisol - a hormone that regulates metabolism, blood sugar, and critically, immune and inflammatory activity.

These systems evolved for short-term survival challenges, and in the acute context, they perform well. Acute stress mobilises the body rapidly in response to threat and can temporarily prime immune defence, reflecting the evolutionary logic that a physical threat might involve injury. Once the threat passes, the response resolves, and the body returns to baseline.

The problem arises when chronic or repeated stress exposure keeps these systems in a state of prolonged activation, with no adequate recovery period. The HPA axis remains activated, cortisol stays elevated, and the sympathetic nervous system runs at a persistently elevated baseline. Over time, what was designed as a short-term survival mechanism becomes a source of sustained physiological dysregulation. The immune system is particularly implicated, and its dysregulation tends to follow two main pathways.

Pathway One: Chronic Inflammation

Inflammation is a necessary and protective response. It helps the body defend against pathogens and repair damaged tissue. Healthy inflammation is targeted and self-resolving, and chronic stress disrupts that resolution. Prolonged HPA axis and sympathetic activation promote the sustained release of pro-inflammatory cytokines (including IL-6, TNF-alpha, and IL-1β) not as a response to a specific threat, but as a persistent background state the immune system cannot switch off.

This low-grade inflammatory state produces no obvious signs of acute inflammation but quietly causes harm over time. Effects include fatigue, poor physical recovery, and increased susceptibility to inflammatory health patterns. More significantly, sustained systemic inflammation is increasingly recognised as a contributor to serious chronic disease - including cardiovascular conditions, where persistent inflammatory signalling can damage vessel walls and promote atherosclerosis, and metabolic conditions such as insulin resistance and type 2 diabetes, where chronic inflammation interferes with normal glucose regulation and cellular signalling.

Pathway Two: Reduced Immune Defence

While chronic stress drives inflammation upward, it simultaneously suppresses the immune functions responsible for identifying and responding to specific threats. Prolonged cortisol exposure reduces T-cell activity, impairs lymphocyte function, and diminishes the immune system's capacity to mount and sustain targeted defence, leaving the body both over-inflammatory and under-defended.

This immune suppression has three main consequences.

Infection susceptibility: Increased vulnerability to common infections is the most immediately recognisable effect. People under chronic stress tend to get sick more frequently, recover more slowly, and experience more severe symptom courses. Wound healing is also impaired. These effects reflect measurable reductions in immune cell function and responsiveness.

Latent viral reactivation: Several common viruses, including HSV, EBV, and CMV, remain dormant in host tissues after initial infection, held in check by ongoing immune surveillance. As chronic stress reduces T-cell activity and antiviral defence, this containment can fail, resulting in recurrent cold sores, shingles flares, or EBV-related symptom patterns.

Abnormal cell control: The same immune surveillance that contains latent viruses also monitors the body's own cells, identifying and clearing those that have become damaged or abnormal before they can accumulate and progress. Natural killer cells and cytotoxic T-cells are central to this process, and chronic stress reduces the function of both. While chronic stress should not be characterised as a direct cause of cancer, impairing the immune pathways responsible for abnormal cell clearance is a consideration worth acknowledging.

Supporting Immune Health Under Chronic Stress

Immune support strategies are significantly limited when chronic stress, poor sleep, and nervous system dysregulation remain unaddressed. Effective support requires working on both sides simultaneously.

Stress reduction

  • Sleep is the body's primary recovery mechanism. Poor sleep amplifies every aspect of stress-related immune dysfunction and should be the first priority
  • Regular moderate exercise has well-documented anti-inflammatory effects. Consistency matters more than intensity
  • Mindfulness, breathwork, therapy, and relaxation practices reduce sympathetic activation and cortisol output
  • Sustained overload has direct immune consequences. Workload boundaries and structured recovery time are not optional
  • Social connection has a measurable buffering effect on the stress response and is associated with healthier immune regulation

Supplements

Supplements work best layered onto the foundations above, not as a substitute for them.

  • Magnesium supports nervous system regulation, sleep quality, and stress reactivity; magnesium glycinate or threonate are generally preferred
  • Vitamin D supports immune regulation; baseline testing is advisable before supplementing, as benefit is most clinically meaningful where deficiency exists, or sun exposure is limited
  • Zinc supports T-cell function and tissue repair; long-term high-dose use warrants clinical oversight due to potential interference with copper absorption
  • Adaptogens (ashwagandha, rhodiola) may support HPA axis regulation and stress resilience; ashwagandha has the stronger evidence base for cortisol reduction and sleep quality; rhodiola is better suited to mental fatigue and energy under stress
  • L-theanine promotes calm focus without sedation and may support restful sleep; useful where stress manifests as mental restlessness

Conclusion

Chronic stress reshapes immune function in two converging ways: it sustains low-grade inflammatory signalling, and it suppresses the protective immune functions the body depends on. Together, these effects increase infection susceptibility, can trigger latent viral reactivation, and may influence pathways relevant to abnormal cell control.

The immune system is responsive to the conditions in which it operates, and meaningful improvement is possible when stress management is treated as a clinical priority rather than an optional add-on. Supplements have a genuine supporting role, but they reach their potential only when the underlying stress burden is consistently managed.

Beyond Saw Palmetto: What the Evidence Shows for Prostate Health Nutraceuticals
Featured
Pippa Spies (Pharmacist) Uncategorised 09 July 2026 0 minutes read

Beyond Saw Palmetto: What the Evidence Shows for Prostate Health Nutraceuticals

What is BPH?

Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland that becomes increasingly common with age, affecting a large proportion of men from their fifties onward. As the prostate enlarges, it can compress the urethra and affect bladder function, giving rise to a cluster of lower urinary tract symptoms (LUTS). These symptoms generally fall into two overlapping categories: voiding symptoms (caused by physical narrowing of the outlet), which may include a weak or interrupted stream, straining to urinate, hesitancy, and a sense of incomplete bladder emptying - and storage symptoms (related to bladder irritability and neuromuscular tone), which may include urinary frequency, urgency, and nocturia (waking at night to urinate). Most men experience some combination of both, though the balance varies considerably from patient to patient, which is part of why no single intervention suits everyone equally.

Nutraceutical support for BPH-related symptoms works through several distinct mechanisms: hormonal, anti-inflammatory, antioxidant, and mild muscle relaxation. Because these ingredients act differently, patients may benefit differently depending on their symptom presentation. And, trialling a nutraceutical option under practitioner guidance (as an adjunct to conventional management) is a reasonable thing to consider.

Beta-sitosterol

How it works: Beta-sitosterol partially inhibits 5-alpha-reductase, the enzyme that converts testosterone into DHT - the hormone most responsible for prostate growth. It works via the same pathway as finasteride, though considerably less potently. It may also have some anti-inflammatory activity in prostate tissue.

Clinically, this means that beta-sitosterol is more likely to help with weak stream, straining, and incomplete emptying than with urgency or frequency, since it targets hormone-driven prostate growth (the growth of which creates a physical blockage) rather than bladder muscle tone. Its effect on DHT is milder than finasteride's, so expect a smaller improvement, not an equivalent one.

Clinical evidence: A review pooling four placebo-controlled trials in 519 men found beta-sitosterol was well tolerated and improved urinary symptom scores and flow in men with mild to moderate BPH; symptom scores improved by almost 5 points more than placebo, with better flow and less residual urine. It did not reduce prostate size compared with placebo, and long-term safety data remain limited.

Saw palmetto

How it works: Saw palmetto's fatty acids and plant sterols act through several routes at once: mild DHT reduction (similar principle to beta-sitosterol), a modest relaxing effect on the bladder neck muscle (same direction as alpha-blockers, much milder), and some anti-inflammatory activity.

Clinically, this means that due to multiple mechanistic pathways, Saw Palmetto may provide benefit for a broader symptom range than beta-sitosterol: the DHT-reduction component may aid the same outlet-narrowing symptoms (weak stream, straining, incomplete emptying) as beta-sitosterol, while the muscle-relaxing component adds potential coverage of urgency, hesitancy, and bladder neck-related obstruction. In principle, this makes it a candidate for patients with a more mixed symptom picture rather than one dominated by a single pattern. Real-world results vary largely between products, tracking with extract concentration and standardisation.

Clinical evidence: A review of 27 studies found saw palmetto alone provided little or no benefit for BPH symptoms, and two NIH-funded trials showed no improvement over placebo. That said, newer, more concentrated extracts have outperformed older, less standardised versions in head-to-head trials, suggesting product quality and standardisation play a meaningful role. Not all saw palmetto products are equivalent.

Lycopene

How it works: Lycopene is a potent antioxidant that protects prostate cells from oxidative damage. It also appears to interfere with growth signals that drive cell proliferation, calm inflammation, and support normal cell-to-cell communication, a process that tends to break down in abnormal cell growth.

Clinically, this means that lycopene may provide slower, cellular-level effects rather than acting on bladder muscle tone or urine flow directly. Lycopene is better positioned for long-term risk reduction than for relieving day-to-day urinary symptoms; it shouldn't be expected to noticeably improve flow the way beta-sitosterol or an alpha-blocker might. It has value as a supportive treatment.

Clinical evidence: The stronger body of evidence relates to prostate cancer risk reduction rather than day-to-day BPH symptoms, and trials on urinary symptoms specifically show only modest benefit. Because of this, lycopene is best used as a supporting ingredient within a broader treatment plan.

Why targeting multiple pathways makes sense

Because beta-sitosterol, saw palmetto, and lycopene each act on different aspects of BPH pathology - hormonal, anti-inflammatory/muscle tone, and oxidative/cellular, respectively - there's a sound rationale for combination treatments. Further, adding nutraceuticals onto prescription treatment may provide additional symptom support. Nutraceuticals have a place in a well-rounded, individualised patient treatment plan.

Conclusion

BPH is not a uniform condition, and symptoms vary from one patient to the next. Beta-sitosterol, saw palmetto, and lycopene each offer a distinct, evidence-supported mechanism, and understanding which symptom pattern each is more likely to influence allows for a more considered, individualised approach rather than a one-size-fits-all recommendation.

Disclaimer: None of the ingredients discussed here have been shown to reduce prostate size, and their supporting evidence relates to general wellness use rather than treatment of a diagnosed medical condition. As with any supplement regimen, patients should be encouraged to discuss nutraceutical options with their treating practitioner or pharmacist, particularly where they are also using prescription therapy such as an alpha-blocker or 5-alpha-reductase inhibitor, or undergoing routine PSA monitoring. Used thoughtfully and under guidance, nutraceuticals can be a reasonable adjunct within a broader, personalised approach to prostate health.

 

Chronic Stress and the Immune System: Inflammation, Infection Risk, and Immune Balance
Pippa Spies (Pharmacist) Uncategorised 11 June 2026 0 minutes read

Chronic Stress and the Immune System: Inflammation, Infection Risk, and Immune Balance

Introduction

Most people think of stress as a mental experience - something to push through, manage, or simply endure. Biologically, it is something more consequential: a coordinated response involving the nervous, endocrine, and immune systems. When a stressor is detected, two major response systems activate. The sympathetic nervous system triggers the immediate fight-or-flight response, releasing adrenaline and noradrenaline. The hypothalamic-pituitary-adrenal (HPA) axis follows, signalling the adrenal cortex to release cortisol - a hormone that regulates metabolism, blood sugar, and critically, immune and inflammatory activity.

These systems evolved for short-term survival challenges, and in the acute context, they perform well. Acute stress mobilises the body rapidly in response to threat and can temporarily prime immune defence, reflecting the evolutionary logic that a physical threat might involve injury. Once the threat passes, the response resolves, and the body returns to baseline.

The problem arises when chronic or repeated stress exposure keeps these systems in a state of prolonged activation, with no adequate recovery period. The HPA axis remains activated, cortisol stays elevated, and the sympathetic nervous system runs at a persistently elevated baseline. Over time, what was designed as a short-term survival mechanism becomes a source of sustained physiological dysregulation. The immune system is particularly implicated, and its dysregulation tends to follow two main pathways.

Pathway One: Chronic Inflammation

Inflammation is a necessary and protective response. It helps the body defend against pathogens and repair damaged tissue. Healthy inflammation is targeted and self-resolving, and chronic stress disrupts that resolution. Prolonged HPA axis and sympathetic activation promote the sustained release of pro-inflammatory cytokines (including IL-6, TNF-alpha, and IL-1β) not as a response to a specific threat, but as a persistent background state the immune system cannot switch off.

This low-grade inflammatory state produces no obvious signs of acute inflammation but quietly causes harm over time. Effects include fatigue, poor physical recovery, and increased susceptibility to inflammatory health patterns. More significantly, sustained systemic inflammation is increasingly recognised as a contributor to serious chronic disease - including cardiovascular conditions, where persistent inflammatory signalling can damage vessel walls and promote atherosclerosis, and metabolic conditions such as insulin resistance and type 2 diabetes, where chronic inflammation interferes with normal glucose regulation and cellular signalling.

Pathway Two: Reduced Immune Defence

While chronic stress drives inflammation upward, it simultaneously suppresses the immune functions responsible for identifying and responding to specific threats. Prolonged cortisol exposure reduces T-cell activity, impairs lymphocyte function, and diminishes the immune system's capacity to mount and sustain targeted defence, leaving the body both over-inflammatory and under-defended.

This immune suppression has three main consequences.

Infection susceptibility: Increased vulnerability to common infections is the most immediately recognisable effect. People under chronic stress tend to get sick more frequently, recover more slowly, and experience more severe symptom courses. Wound healing is also impaired. These effects reflect measurable reductions in immune cell function and responsiveness.

Latent viral reactivation: Several common viruses, including HSV, EBV, and CMV, remain dormant in host tissues after initial infection, held in check by ongoing immune surveillance. As chronic stress reduces T-cell activity and antiviral defence, this containment can fail, resulting in recurrent cold sores, shingles flares, or EBV-related symptom patterns.

Abnormal cell control: The same immune surveillance that contains latent viruses also monitors the body's own cells, identifying and clearing those that have become damaged or abnormal before they can accumulate and progress. Natural killer cells and cytotoxic T-cells are central to this process, and chronic stress reduces the function of both. While chronic stress should not be characterised as a direct cause of cancer, impairing the immune pathways responsible for abnormal cell clearance is a consideration worth acknowledging.

Supporting Immune Health Under Chronic Stress

Immune support strategies are significantly limited when chronic stress, poor sleep, and nervous system dysregulation remain unaddressed. Effective support requires working on both sides simultaneously.

Stress reduction

  • Sleep is the body's primary recovery mechanism. Poor sleep amplifies every aspect of stress-related immune dysfunction and should be the first priority
  • Regular moderate exercise has well-documented anti-inflammatory effects. Consistency matters more than intensity
  • Mindfulness, breathwork, therapy, and relaxation practices reduce sympathetic activation and cortisol output
  • Sustained overload has direct immune consequences. Workload boundaries and structured recovery time are not optional
  • Social connection has a measurable buffering effect on the stress response and is associated with healthier immune regulation

Supplements

Supplements work best layered onto the foundations above, not as a substitute for them.

  • Magnesium supports nervous system regulation, sleep quality, and stress reactivity; magnesium glycinate or threonate are generally preferred
  • Vitamin D supports immune regulation; baseline testing is advisable before supplementing, as benefit is most clinically meaningful where deficiency exists, or sun exposure is limited
  • Zinc supports T-cell function and tissue repair; long-term high-dose use warrants clinical oversight due to potential interference with copper absorption
  • Adaptogens (ashwagandha, rhodiola) may support HPA axis regulation and stress resilience; ashwagandha has the stronger evidence base for cortisol reduction and sleep quality; rhodiola is better suited to mental fatigue and energy under stress
  • L-theanine promotes calm focus without sedation and may support restful sleep; useful where stress manifests as mental restlessness

Conclusion

Chronic stress reshapes immune function in two converging ways: it sustains low-grade inflammatory signalling, and it suppresses the protective immune functions the body depends on. Together, these effects increase infection susceptibility, can trigger latent viral reactivation, and may influence pathways relevant to abnormal cell control.

The immune system is responsive to the conditions in which it operates, and meaningful improvement is possible when stress management is treated as a clinical priority rather than an optional add-on. Supplements have a genuine supporting role, but they reach their potential only when the underlying stress burden is consistently managed.

  1. SAHPRA Response
  2. Cardiovascular Health and Evidence-Based Supplementation
  3. Hormone Replacement Therapy: Reassessing Risk, Restoring Balance
  4. Cortisol in Context: Separating Fact from Fiction

Page 1 of 2

  • 1
  • 2
Copyright © 2025 iDEXIS. All Rights Reserved. Designed by iDEXIS
iDexis
  • About
  • Services
  • Orders
  • Product Range
  • Blog
  • Clients
  • Contact us
We use cookies to ensure that we give you the best experience on our website.
I accept